COVID-19 test
Our Company is the exclusive global distributor of the first Polish COVID-19 antigen and antibody tests being distributed from January 2021 onward.
We also distribute RT-PCR tests made by our Polish partner,
White label / private label
We offer white label product range covering hemp plant, flower, fiber, seeds, oil, cosmetics, CBD oils and edibles, beer and beverages, vaporizers, cartridges, and other.
HW is now talking to buyers from all over the world of the above cultivated/produced goods.
Province Brand of Canada
Province Brands of Canada is the company behind a transformative technology for creating both (1) sugars for beverage fermentation (e.g. for brewing beer/ nonalcoholic beer) and (2) lower calorie, lower glycemic index sweeteners (when compared to sucrose / other commercial sweeteners) for use in food and beverage from just about any type of cellulosic plant waste biomass (including agricultural byproducts and residual material from the legal hemp and marijuana industries).
Hemp & Health has the exclusive right to represent Province Brands of Canada’s proprietary saccharification and brewing technologies to beverage makers and others in Poland’s alcohol, cannabis (CBD), and food / beverage industries. Hemp & Health also has the nonexclusive right to represent Province Brands’ technologies throughout the whole of Europe. Following an “onboarding period”, Hemp & Health intends to introduce Province Brands’ technologies to brewers, food and beverage makers and other prospective licensees with the goal of licensing the technology. Licensees may create products of their own design or produce Province Brands’ internally developed products / brands, including Cambridge Bay Canadian Hemp Lager, a beer produced using Province Brands’ technology and brewed from only water, food-grade hemp, hops and yeast with no grain, starch or sugar used in the fermentation process.
R&D
Our company is planning the R&D activities related to the use of CBD / THC cannabinoids to combat the effects and prevent recurrence of the COVID-19 coronavirus epidemic. These steps will be taken as a result of the analysis of the possibility of using our own competences, as well as the use of the competences of our partners acquired by the Company.